A study of MDPL3280A in patients with advanced bladder cancer

Mise à jour : Il y a 4 ans
Référence : EUCTR2013-005486-39

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

Evaluated the efficacy of MPDL3280A in patients with locally advanced or metastatic urothelial bladder cancer as measured by independent review facility assessed ORR using RECIST v1.1 and investigator assess ORR according to modified RECIST (this is applicable only to Cohort 2)


Critère d'inclusion

  • bladder cancer